News
-
Optomeditech will present OptiVein IV catheters during the 33rd Annual Scientific Meeting of Association for Vascular Access (AVA) in Las Vegas. Come and visit us at our booth #635. We're looking forw.. Read more
-
The U.S. Patent and Trademark Office published a patent for Optomeditech Oy on July 11, 2017 entitled "Intravascular Catheter Assembly." The granted patent is a culmination of years of determined.. Read more
-
Optomeditech Oy gets $ 2.5 Million in Funding from Lifeline Ventures and Sitra, The Finnish Innovation Fund! Read the latest publications on Optomeditech Oy: http://www.arcticstartup.com/2014/12.. Read more
-
Optomeditech has successfully secured ISO 13485 certificate of Quality Management System and has obtained CE mark approval for its OptiVein System to aid in IV cannulation. These are two important .. Read more
-
Talouselämä listed Optomeditech among 20 top promissing start ups in 2014. http://www.talouselama.fi/Kasvuyritykset/talouselama+valitsi+tassa+ovat+suomen+20+lupaavinta+alkuvaiheen+yritysta/a2229059 .. Read more
-
Optomeditech Oy participated in the MedTech Nordic investing and Partnering event on September 3, 2013 in Helsinki as one of the 30 leading Nordic start-ups presenting in the event. The presenting com.. Read more
-
10.07.2013Today Optomeditech Oy passed Stage 1 of its ISO 13485 certification process to become a full designer and producer of Medical Devices. Read more
-
Optomeditech will participate in the Medtech Nordic Investing & Partnering event on September 3, 2013 at Finlandia Hall conference center in Helsinki, Finland as one of the 30 selected presenting comp.. Read more
-
Optomeditech Oy began its initial clinical testing at the Helsinki University Hospital for its new IV-catheter today. The initial test will run until the end of August 2013 and will yield results on t.. Read more
